Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarclays Regulatory News (BARC)

Share Price Information for Barclays (BARC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 192.24
Bid: 192.24
Ask: 192.28
Change: 3.06 (1.62%)
Spread: 0.04 (0.021%)
Open: 191.24
High: 193.58
Low: 190.48
Prev. Close: 189.18
BARC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD

10 Dec 2018 12:02

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Barclays PLC.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TAKEDA PHARMACEUTICAL CO LTD

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

07 DEC 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

YES SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary NPV
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 12,025,257 1.51% 13,652,404 1.72%
(2) Cash-settled derivatives:
13,258,888 1.67% 10,885,300 1.37%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 10,521,600 1.32% 10,941,600 1.38%
(4)
TOTAL: 35,805,745 4.51% 35,479,304 4.46%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ADR Purchase 2,642 16.9900 USD
ADR Purchase 9,058 17.0825 USD
ADR Purchase 62,407 16.9097 USD
ADR Purchase 83,300 16.9584 USD
ADR Purchase 102,907 17.8300 USD
ADR Sale 1,230 16.9600 USD
ADR Sale 2,642 16.9524 USD
ADR Sale 9,058 17.0825 USD
ADR Sale 24,198 16.9373 USD
ADR Sale 62,407 16.9097 USD
ADR Sale 102,907 17.8300 USD
Ordinary NPV Purchase 12 3,931.0833 JPY
Ordinary NPV Purchase 75 3,934.8242 JPY
Ordinary NPV Purchase 82 3,933.5487 JPY
Ordinary NPV Purchase 100 3,944.6700 JPY
Ordinary NPV Purchase 100 3,973.9000 JPY
Ordinary NPV Purchase 100 3,999.0000 JPY
Ordinary NPV Purchase 143 3,938.4615 JPY
Ordinary NPV Purchase 200 3,886.0000 JPY
Ordinary NPV Purchase 300 4,009.9000 JPY
Ordinary NPV Purchase 357 3,934.5378 JPY
Ordinary NPV Purchase 400 4,000.0000 JPY
Ordinary NPV Purchase 731 3,929.7711 JPY
Ordinary NPV Purchase 900 3,980.0000 JPY
Ordinary NPV Purchase 2,000 3,965.0500 JPY
Ordinary NPV Purchase 4,000 3,897.9125 JPY
Ordinary NPV Purchase 4,900 3,932.3163 JPY
Ordinary NPV Purchase 4,900 3,916.5612 JPY
Ordinary NPV Purchase 5,000 3,951.0600 JPY
Ordinary NPV Purchase 5,300 3,938.8113 JPY
Ordinary NPV Purchase 5,600 3,923.1250 JPY
Ordinary NPV Purchase 5,600 3,923.6160 JPY
Ordinary NPV Purchase 5,700 3,914.0070 JPY
Ordinary NPV Purchase 5,700 3,936.5877 JPY
Ordinary NPV Purchase 6,100 3,898.9049 JPY
Ordinary NPV Purchase 6,800 3,892.8382 JPY
Ordinary NPV Purchase 7,200 4,002.6944 JPY
Ordinary NPV Purchase 10,300 3,918.6456 JPY
Ordinary NPV Purchase 11,800 3,912.6610 JPY
Ordinary NPV Purchase 15,500 3,889.0000 JPY
Ordinary NPV Purchase 19,400 3,979.9072 JPY
Ordinary NPV Purchase 51,700 4,104.0003 JPY
Ordinary NPV Purchase 100,000 3,900.4470 JPY
Ordinary NPV Purchase 101,100 3,886.3214 JPY
Ordinary NPV Purchase 200,300 3,954.2576 JPY
Ordinary NPV Purchase 228,200 3,937.7436 JPY
Ordinary NPV Purchase 359,700 3,927.3578 JPY
Ordinary NPV Purchase 472,900 3,947.7107 JPY
Ordinary NPV Purchase 1,054,100 3,943.7209 JPY
Ordinary NPV Purchase 1,056,700 3,942.2793 JPY
Ordinary NPV Sale 100 3,999.0000 JPY
Ordinary NPV Sale 100 3,973.9000 JPY
Ordinary NPV Sale 100 3,973.5000 JPY
Ordinary NPV Sale 200 3,974.5000 JPY
Ordinary NPV Sale 600 4,022.0266 JPY
Ordinary NPV Sale 700 3,974.0000 JPY
Ordinary NPV Sale 900 3,937.2222 JPY
Ordinary NPV Sale 2,000 3,965.0500 JPY
Ordinary NPV Sale 3,200 3,894.2500 JPY
Ordinary NPV Sale 4,000 3,897.9125 JPY
Ordinary NPV Sale 4,300 3,915.9535 JPY
Ordinary NPV Sale 4,900 3,932.3163 JPY
Ordinary NPV Sale 5,300 3,936.6603 JPY
Ordinary NPV Sale 5,700 3,914.0070 JPY
Ordinary NPV Sale 5,700 3,936.5877 JPY
Ordinary NPV Sale 6,400 3,904.1078 JPY
Ordinary NPV Sale 7,200 3,968.3888 JPY
Ordinary NPV Sale 9,800 3,916.6581 JPY
Ordinary NPV Sale 10,600 3,920.7122 JPY
Ordinary NPV Sale 16,400 3,995.9878 JPY
Ordinary NPV Sale 17,700 3,975.5254 JPY
Ordinary NPV Sale 20,000 4,000.0000 JPY
Ordinary NPV Sale 50,000 3,888.7860 JPY
Ordinary NPV Sale 51,100 3,883.9099 JPY
Ordinary NPV Sale 145,400 3,904.6698 JPY
Ordinary NPV Sale 200,300 3,953.3235 JPY
Ordinary NPV Sale 1,056,700 3,942.2793 JPY
Ordinary NPV Sale 1,174,000 3,940.6373 JPY
Ordinary NPV Sale 1,324,100 3,949.7934 JPY
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
Ordinary NPV SWAP Long 600 4,022.0256 JPY
Ordinary NPV SWAP Long 3,100 3,944.5000 JPY
Ordinary NPV CFD Long 14,100 4,000.4155 JPY
Ordinary NPV CFD Long 200,000 3,988.0547 JPY
Ordinary NPV SWAP Short 12 3,931.0597 JPY
Ordinary NPV SWAP Short 75 3,934.8242 JPY
Ordinary NPV SWAP Short 82 3,933.5467 JPY
Ordinary NPV SWAP Short 100 3,944.6755 JPY
Ordinary NPV SWAP Short 143 3,938.4652 JPY
Ordinary NPV SWAP Short 200 3,976.0000 JPY
Ordinary NPV SWAP Short 300 3,928.5000 JPY
Ordinary NPV SWAP Short 357 3,934.5393 JPY
Ordinary NPV SWAP Short 731 3,929.7723 JPY
Ordinary NPV SWAP Short 3,100 3,944.5000 JPY
Ordinary NPV CFD Short 51,700 4,104.0000 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

10 DEC 2018

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure:

Barclays PLC.

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

TAKEDA PHARMACEUTICAL CO LTD

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
Ordinary NPV Call Options Purchased 39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 40,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -460,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Written -104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Call Options Written -78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Call Options Written -70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Purchased -39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Written 75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Put Options Written 78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Put Options Written 114,000 4750.0200 European 14 May 2019
Call Options Purchased 10,000,000 4206.0397 European 7 Jan 2019
Call Options Written -10,000,000 4206.0397 European 7 Jan 2019
Put Options Purchased -10,000,000 4206.0397 European 7 Jan 2019
Put Options Written 10,000,000 4206.0397 European 0 Jan 1900

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181210005346/en/

Copyright Business Wire 2018

Date   Source Headline
23rd Apr 20243:26 pmRNSForm 8.3 - WINCANTON PLC
23rd Apr 20243:26 pmRNSForm 8.3 - VIRGIN MONEY UK PLC
23rd Apr 20243:26 pmRNSForm 8.3 - TYMAN PLC
23rd Apr 20243:26 pmRNSForm 8.3 - UK COMMERCIAL PROPERTY REIT LTD
23rd Apr 20243:26 pmRNSForm 8.3 - QUANEX BUILDING PRODUCTS CORP
23rd Apr 20243:26 pmRNSForm 8.3 - TRITAX BIG BOX REIT PLC
23rd Apr 20243:25 pmRNSForm 8.3 - SPIRENT COMMUNICATIONS PLC
23rd Apr 20243:25 pmRNSForm 8.3 - INTERNATIONAL PAPER CO
23rd Apr 20243:25 pmRNSForm 8.3 - NETWORK INTERNATIONAL HOLDINGS PLC
23rd Apr 20243:25 pmRNSForm 8.3 - MATTIOLI WOODS PLC
23rd Apr 20243:24 pmRNSForm 8.3 -LOK'NSTORE GROUP PLC
23rd Apr 20243:24 pmRNSForm 8.3 - KIN & CARTA PLC
23rd Apr 20243:24 pmRNSForm 8.3 - DS SMITH PLC
23rd Apr 202411:37 amRNS38.5(b)- IRISH RESIDENTIAL PROPERTIES REIT PLC
23rd Apr 202411:35 amRNSForm 8.5 (EPT/NON-RI)REDROW PLC
23rd Apr 202411:34 amRNSForm8.5(EPT/NON-RI)INTERNATIONAL DISTRIBUT SERVI
23rd Apr 202411:34 amRNSForm 8.5 (EPT/NON-RI)GCP ASSET BACKED INCOME FUND
23rd Apr 202411:33 amRNSForm 8.5 (EPT/NON-RI)BARRATT DEVELOPMENTS PLC
23rd Apr 202411:33 amRNSForm8.5(EPT/NON-RI)BALANCED COMMERCIAL PROPE TRUS
23rd Apr 20247:30 amRNSTransaction in Own Shares
22nd Apr 20242:29 pmRNSForm 8.3 - WINCANTON PLC
22nd Apr 20242:29 pmRNSForm 8.3 - UK COMMERCIAL PROPERTY REIT LTD
22nd Apr 20242:29 pmRNSForm 8.3 -VIRGIN MONEY UK PLC
22nd Apr 20242:28 pmRNSForm 8.3 -TRITAX BIG BOX REIT PLC
22nd Apr 20242:28 pmRNSForm 8.3 - SPIRENT COMMUNICATIONS PLC
22nd Apr 20242:28 pmRNSForm 8.3 - MONDI PLC
22nd Apr 20242:27 pmRNSForm 8.3 - NETWORK INTERNATIONAL HOLDINGS PLC
22nd Apr 20242:26 pmRNSForm 8.3 -MATTIOLI WOODS PLC
22nd Apr 20242:25 pmRNSForm 8.3 - LOK'NSTORE GROUP PLC
22nd Apr 20242:25 pmRNSForm 8.3 - KIN & CARTA PLC
22nd Apr 20242:25 pmRNSForm 8.3 - INTERNATIONAL PAPER CO
22nd Apr 20242:24 pmRNSForm 8.3 - HIPGNOSIS SONGS FUND LTD/THE FUND
22nd Apr 20242:24 pmRNSForm 8.3 -DS SMITH PLC
22nd Apr 202412:03 pmRNS38.5(b) Report - IRISH RESIDENTIAL PROPERTIE REIT
22nd Apr 202411:49 amRNSForm 8.5 (EPT/NON-RI)REDROW PLC
22nd Apr 202411:49 amRNSForm 8.5 (EPT/NON-RI)GCP ASSET BACKED INCOME FUND
22nd Apr 202411:48 amRNSForm 8.5 (EPT/NON-RI)BARRATT DEVELOPMENTS PLC
22nd Apr 202411:48 amRNSForm8.5(EPT/NON-RI)INTERNATIONAL DISTRIBUTION SERV
22nd Apr 202411:48 amRNSForm 8.5 (EPT/NON-RI)BALANCED COMMERCIAL PROPE TRU
22nd Apr 20247:30 amRNSTransaction in Own Shares
19th Apr 20242:55 pmRNSForm 8.3 - VIRGIN MONEY UK PLC
19th Apr 20242:54 pmRNSForm 8.3 - WINCANTON PLC
19th Apr 20242:54 pmRNSForm 8.3 -UK COMMERCIAL PROPERTY REIT LTD
19th Apr 20242:54 pmRNSForm 8.3 - TRITAX BIG BOX REIT PLC
19th Apr 20242:54 pmRNSForm 8.3 - NETWORK INTERNATIONAL HOLDINGS PLC
19th Apr 20242:54 pmRNSForm 8.3 - INTERNATIONAL PAPER CO
19th Apr 20242:54 pmRNSForm 8.3 - SPIRENT COMMUNICATIONS PLC
19th Apr 20242:53 pmRNSForm 8.3 - MONDI PLC
19th Apr 20242:53 pmRNSForm 8.3 - KIN & CARTA PLC
19th Apr 20242:51 pmRNSForm 8.3 - HIPGNOSIS SONGS FUND LTD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.